Area of research
Immunology · Rheumatology
Research interest
Research interests include Psoriasis: Treatment and Pathogenesis, Spondyloarthritis Studies and Treatments, Dermatology and Skin Diseases, and Rheumatoid Arthritis Research and Therapies.
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials
Etanercept ameliorates psoriasis progression through regulating high mobility group box 1 pathway
Gut microbiota from patients with arteriosclerotic CSVD induces higher IL-17A production in neutrophils via activating RORγt
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparator–controlled VOYAGE 2 trial
A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis
Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: Results of the randomized phase 3 CADMUS study
Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo‐Controlled Phase III Trial
Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
I-Corps: Cloud-based Water Resources Simulations
A Hierarchical and Patch Dynamics Paradigm for Modeling Complex, 3D Groundwater Systems Across Multiple Scales
SEI+II (GEO): An IT-Enabled, Hierarchical and Patch Dynamic Environment for Modeling Complex, 3D Groundwater Systems Across Multiple Spatial Scales
VIRGE: Virtual Interactive Remediation in the Groundwater Environment - An Action Oriented Curriculum Innovation in Environmental Engineering
VIRGE: Virtual Interactive Remediation in the Groundwater Environment - An Action Oriented Curriculum Innovation in Environmental Engineering
Stochastic Flow and Transport in Heterogeneous Soils: Nonstationarity, Scale Interaction, and an Efficient Modeling Framework
Stochastic Flow and Transport in Heterogeneous Soils: Nonstationarity, Scale Interaction, and an Efficient Modeling Framework
Stochastic Flow and Transport in Heterogeneous Soils: A New Approach for Measurement Conditioning
Reductive Dual Pairs in Exceptional Groups: Cohomology, and Unipotent Representations
Mathematical Sciences: Singular Unitary Representations and Cohomology of Arithmetic Manifolds
Mathematical Sciences: Discrete Spectrum of the Oscillator Representation and Applications
Mathematical Sciences: Theta Lifting and Cohomology of Discrete Subgroups